Experienced in Hyperparathyroidism

Dong G. Yan

31 Xinjiekou East Street, 
Beijing, CN 
Experienced in Hyperparathyroidism
31 Xinjiekou East Street, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Dong Yan practices in Beijing, China. Mr. Yan is rated as an Experienced expert by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Liver Cancer, Caffey Disease, Colorectal Cancer, Thyroidectomy, and Endoscopy.

His clinical research consists of co-authoring 147 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hyperparathyroidism.

Gender
Male

Locations

31 Xinjiekou East Street, Beijing, 100035, China
Other Locations
Workers Stadium South Road, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drugs: TQB2450, Anlotinib
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Open-label, Single-arm, Phase Ib Study to Evaluate the Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Gastric Carcinoma
A Multicenter, Open-label, Single-arm, Phase Ib Study to Evaluate the Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Gastric Carcinoma
Enrollment Status: Terminated
Publish Date: March 07, 2024
Intervention Type: Drug
Study Drug: Liposomal Mitoxantrone
Study Phase: Phase 1
View 2 Less Clinical Trials

147 Total Publications

Genome-wide identification and expression profiles of the superoxide dismutase (SOD) genes in Lentinula edodes.
Genome-wide identification and expression profiles of the superoxide dismutase (SOD) genes in Lentinula edodes.
Journal: International journal of biological macromolecules
Published: June 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yan's expertise for a condition
ConditionClose
        View All 42 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile